Cardiovascular Devices from Medtronic, Inc. Featured Prominently at EuroPCR

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE: MDT), announced today the schedule of important clinical data presentations during EuroPCR, a major cardiology meeting taking place May 25–28 in Paris at the Palais de Congrès.

MORE ON THIS TOPIC